The effect of newer antiarrhythmic drugs on defibrillation threshold. 1980

W A Tacker, and M J Niebauer, and C F Babbs, and W J Combs, and B M Hahn, and M A Barker, and J F Seipel, and J D Bourland, and L A Geddes

This study was conducted to determine the effects of clofilium phosphate and bretylium tosylate on ventricular defibrillation threshold. Dogs were anesthetized with pentobarbital and subjected to repeated fibrillation-defibrillation episodes. Defibrillation thresholds were determined at 15-min intervals, using underdamped 5--6 msec sinusoidal current shocks, from 30 min before drug injection to 120 min after injection. Eight dogs were given clofilium phosphate (0.34 mg/kg, iv). Another 10 dogs were given bretylium tosylate (10.0 mg/kg, iv). Both drugs lowered defibrillation threshold from 15--90 min after injection. The maximum clofilium effect was a 31% decrease in threshold current and a 54% decrease in threshold energy. The greatest decrease in defibrillation threshold produced by bretylium was 16% for current and 31% for energy. These drug induced changes in defibrillation threshold are of potential clinical benefit if they occur in human subjects at doses which are effective for control of ventricular arrhythmias.

UI MeSH Term Description Entries
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D001950 Bretylium Tosylate An agent that blocks the release of adrenergic transmitters and may have other actions. It was formerly used as an antihypertensive agent, but is now proposed as an anti-arrhythmic. Bretylate,Bretylium Tosilate,Bretylol,Ornid
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004554 Electric Countershock An electrical current applied to the HEART to terminate a CARDIAC ARRHYTHMIA. Cardiac Electroversion,Cardioversion,Defibrillation, Electric,Electroversion, Cardiac,Electrical Cardioversion,Electroversion Therapy,Therapy, Electroversion,Cardiac Electroversions,Cardioversion, Electrical,Cardioversions,Cardioversions, Electrical,Countershock, Electric,Countershocks, Electric,Defibrillations, Electric,Electric Countershocks,Electric Defibrillation,Electric Defibrillations,Electrical Cardioversions,Electroversion Therapies,Electroversions, Cardiac,Therapies, Electroversion
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D014693 Ventricular Fibrillation A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST. Fibrillation, Ventricular,Fibrillations, Ventricular,Ventricular Fibrillations

Related Publications

W A Tacker, and M J Niebauer, and C F Babbs, and W J Combs, and B M Hahn, and M A Barker, and J F Seipel, and J D Bourland, and L A Geddes
September 1979, American heart journal,
W A Tacker, and M J Niebauer, and C F Babbs, and W J Combs, and B M Hahn, and M A Barker, and J F Seipel, and J D Bourland, and L A Geddes
May 1981, Critical care medicine,
W A Tacker, and M J Niebauer, and C F Babbs, and W J Combs, and B M Hahn, and M A Barker, and J F Seipel, and J D Bourland, and L A Geddes
November 1986, The West Virginia medical journal,
W A Tacker, and M J Niebauer, and C F Babbs, and W J Combs, and B M Hahn, and M A Barker, and J F Seipel, and J D Bourland, and L A Geddes
January 2001, Indian heart journal,
W A Tacker, and M J Niebauer, and C F Babbs, and W J Combs, and B M Hahn, and M A Barker, and J F Seipel, and J D Bourland, and L A Geddes
October 1978, Pacing and clinical electrophysiology : PACE,
W A Tacker, and M J Niebauer, and C F Babbs, and W J Combs, and B M Hahn, and M A Barker, and J F Seipel, and J D Bourland, and L A Geddes
March 1988, The Medical clinics of North America,
W A Tacker, and M J Niebauer, and C F Babbs, and W J Combs, and B M Hahn, and M A Barker, and J F Seipel, and J D Bourland, and L A Geddes
April 1979, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
W A Tacker, and M J Niebauer, and C F Babbs, and W J Combs, and B M Hahn, and M A Barker, and J F Seipel, and J D Bourland, and L A Geddes
April 1981, The Western journal of medicine,
W A Tacker, and M J Niebauer, and C F Babbs, and W J Combs, and B M Hahn, and M A Barker, and J F Seipel, and J D Bourland, and L A Geddes
April 1992, Pacing and clinical electrophysiology : PACE,
W A Tacker, and M J Niebauer, and C F Babbs, and W J Combs, and B M Hahn, and M A Barker, and J F Seipel, and J D Bourland, and L A Geddes
January 1988, Pacing and clinical electrophysiology : PACE,
Copied contents to your clipboard!